Orser Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,833
Closed -$3.46M 89
2021
Q4
$3.46M Sell
12,833
-623
-5% -$154K 1.75% 23
2021
Q3
$3.25M Buy
13,456
+291
+2% +$73.3K 1.79% 21
2021
Q2
$3.12M Buy
13,165
+99
+0.8% +$22.6K 1.61% 26
2021
Q1
$2.86M Sell
13,066
-1,106
-8% -$222K 1.86% 21
2020
Q4
$2.48M Buy
14,172
+1,653
+13% +$286K 1.57% 23
2020
Q3
$2.02M Sell
12,519
-495
-4% -$78.5K 1.6% 25
2020
Q2
$1.86M Buy
+13,014
New +$1.8M 1.68% 24

Other funds holding LH

Orser Capital Management's LH Position: Q1 2022 in Review

Orser Capital Management sold out of Labcorp (LH) in Q1 2022, closing a stake of 12,833 shares — an estimated $3.46M sold.

Orser Capital Management first reported a position in LH in Q2 2020 and held it in 7 quarters. The position peaked at $3.46M in Q4 2021. 1,034 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • Orser Capital Management reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
  • Orser Capital Management sold 12,833 Labcorp shares in Q1 2022, an estimated $3.46M.
  • Orser Capital Management first reported a position in Labcorp in Q2 2020 and held it in 7 quarters.
  • Orser Capital Management's Labcorp position peaked at $3.46M in Q4 2021.
  • 1,034 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Orser Capital Management's 13F filing for Q1 2022, filed 11 Apr 2022.